These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 25697038)

  • 21. [Female gender and pulmonary arterial hypertension: a complex relationship].
    Manes A; Palazzini M; Dardi F; D'Adamo A; Rinaldi A; Galiè N
    G Ital Cardiol (Rome); 2012 Jun; 13(6):448-60. PubMed ID: 22622125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Updated clinical classification of pulmonary hypertension].
    Simonneau G; Gatzoulis MA; Adatia I; Celermajer D; Denton C; Ghofrani A; Gomez Sanchez MA; Kumar RK; Landzberg M; Machado RF; Olschewski H; Robbins IM; Souza R
    Turk Kardiyol Dern Ars; 2014 Oct; 42 Suppl 1():45-54. PubMed ID: 25697033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrent glioblastoma: a fresh look at current therapies and emerging novel approaches.
    Gilbert MR
    Semin Oncol; 2011 Dec; 38 Suppl 4():S21-33. PubMed ID: 22078645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current therapies for pulmonary arterial hypertension.
    Takaoka S; Faul JL; Doyle R
    Semin Cardiothorac Vasc Anesth; 2007 Jun; 11(2):137-48. PubMed ID: 17536117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical trial design and new therapies for pulmonary arterial hypertension.
    Sitbon O; Gomberg-Maitland M; Granton J; Lewis MI; Mathai SC; Rainisio M; Stockbridge NL; Wilkins MR; Zamanian RT; Rubin LJ
    Eur Respir J; 2019 Jan; 53(1):. PubMed ID: 30545975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New and future therapies in pulmonary arterial hypertension.
    Bull TM
    Semin Respir Crit Care Med; 2005 Aug; 26(4):429-36. PubMed ID: 16121320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of dyspnea in advanced pulmonary arterial hypertension.
    Sajkov D; Petrovsky N; Palange P
    Curr Opin Support Palliat Care; 2010 Jun; 4(2):76-84. PubMed ID: 20407377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection, evaluation, and treatment of severe and resistant hypertension: proceedings from an American Society of Hypertension Interactive forum held in Bethesda, MD, U.S.A., October 10th 2013.
    White WB; Turner JR; Sica DA; Bisognano JD; Calhoun DA; Townsend RR; Aronow HD; Bhatt DL; Bakris GL
    J Am Soc Hypertens; 2014 Oct; 8(10):743-57. PubMed ID: 25418497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of combination therapy in the treatment of pulmonary arterial hypertension.
    Abraham T; Wu G; Vastey F; Rapp J; Saad N; Balmir E
    Pharmacotherapy; 2010 Apr; 30(4):390-404. PubMed ID: 20334459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted therapies in pulmonary arterial hypertension.
    Montani D; Chaumais MC; Guignabert C; Günther S; Girerd B; Jaïs X; Algalarrondo V; Price LC; Savale L; Sitbon O; Simonneau G; Humbert M
    Pharmacol Ther; 2014 Feb; 141(2):172-91. PubMed ID: 24134901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Definitions and diagnosis of pulmonary hypertension].
    Hoeper MM; Bogaard HJ; Condliffe R; Frantz R; Khanna D; Kurzyna M; Langleben D; Manes A; Satoh T; Torres F; Wilkins MR; Badesch DB
    Turk Kardiyol Dern Ars; 2014 Oct; 42 Suppl 1():55-66. PubMed ID: 25697034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting of platelet-derived growth factor signaling in pulmonary arterial hypertension.
    Berghausen E; ten Freyhaus H; Rosenkranz S
    Handb Exp Pharmacol; 2013; 218():381-408. PubMed ID: 24092349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacologic and pharmacokinetic rationale for combination therapy in pulmonary arterial hypertension.
    Gokhman R; Smithburger PL; Kane-Gill SL; Seybert AL
    J Cardiovasc Pharmacol; 2010 Dec; 56(6):686-95. PubMed ID: 20838230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Animal models related to congenital heart disease and clinical research in pulmonary hypertension.
    Loukanov T; Geiger R; Agrawal R
    Cardiology; 2010; 116(1):18-25. PubMed ID: 20424448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Existing drugs and agents under investigation for pulmonary arterial hypertension.
    Sharma M; Pinnamaneni S; Aronow WS; Jozwik B; Frishman WH
    Cardiol Rev; 2014; 22(6):297-305. PubMed ID: 25098201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic targets in neonatal pulmonary hypertension: linking pathophysiology to clinical medicine.
    van der Horst IW; Reiss I; Tibboel D
    Expert Rev Respir Med; 2008 Feb; 2(1):85-96. PubMed ID: 20477225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pediatric pulmonary hypertension].
    Ivy DD; Abman SH; Barst RJ; Berger RM; Bonnet D; Fleming TR; Haworth SG; Raj JU; Rosenzweig EB; Neick IS; Steinhorn RH; Beghetti M
    Turk Kardiyol Dern Ars; 2014 Oct; 42 Suppl 1():153-64. PubMed ID: 25697042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Key articles and guidelines in the management of pulmonary arterial hypertension: 2011 update.
    Johnson SG; Kayser SR; Attridge RL; Duvall L; Kiser TH; Moote R; Reed BN; Rodgers JE; Erstad B
    Pharmacotherapy; 2012 Jun; 32(6):e134-69. PubMed ID: 22467427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulmonary arterial hypertension: challenges in translational research and a vision for change.
    Sutendra G; Michelakis ED
    Sci Transl Med; 2013 Oct; 5(208):208sr5. PubMed ID: 24154604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary hypertension in 2012: contemporary issues in diagnosis and management.
    Lau EM; Corte TJ
    Panminerva Med; 2012 Mar; 54(1):11-28. PubMed ID: 22278113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.